Bank of America’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-469,500
Closed -$46.6M 7767
2019
Q3
$46.6M Buy
469,500
+50,300
+12% +$4.78M 0.01% 1177
2019
Q2
$38.8M Sell
419,200
-740,700
-64% -$70.3M 0.01% 1326
2019
Q1
$109M Buy
1,159,900
+713,400
+160% +$62.4M 0.02% 704
2018
Q4
$28.6M Sell
446,500
-24,900
-5% -$1.84M 0.01% 1400
2018
Q3
$42.2M Buy
471,400
+41,100
+10% +$3.63M 0.01% 1222
2018
Q2
$34.2M Buy
430,300
+108,000
+34% +$8.97M 0.01% 1370
2018
Q1
$28.8M Sell
322,300
-160,400
-33% -$15.4M ﹤0.01% 1472
2017
Q4
$50.4M Buy
482,700
+91,700
+23% +$10.3M 0.01% 1084
2017
Q3
$57M Sell
391,000
-30,000
-7% -$4.09M 0.01% 1055
2017
Q2
$54.7M Sell
421,000
-264,200
-39% -$32.4M 0.01% 992
2017
Q1
$85.3M Buy
685,200
+447,100
+188% +$53.5M 0.02% 759
2016
Q4
$27.6M Buy
238,100
+7,300
+3% +$813K 0.01% 1416
2016
Q3
$24.1M Sell
230,800
-50,600
-18% -$5.48M 0.01% 1511
2016
Q2
$27.8M Sell
281,400
-159,900
-36% -$16.5M 0.01% 1359
2016
Q1
$44.2M Buy
441,300
+50,000
+13% +$5.15M 0.01% 1003
2015
Q4
$46.9M Buy
391,300
+147,200
+60% +$17M 0.01% 1035
2015
Q3
$26.4M Sell
244,100
-31,100
-11% -$3.86M 0.01% 1403
2015
Q2
$31.9M Sell
275,200
-600
-0.2% -$68.6K 0.01% 1094
2015
Q1
$31.8M Sell
275,800
-177,000
-39% -$21.2M 0.01% 1060
2014
Q4
$50.6M Sell
452,800
-65,000
-13% -$6.86M 0.02% 840
2014
Q3
$49.1M Sell
517,800
-216,300
-29% -$19.5M 0.02% 856
2014
Q2
$63M Buy
734,100
+407,300
+125% +$31M 0.02% 721
2014
Q1
$22.8M Buy
326,800
+203,600
+165% +$16.1M 0.01% 1203
2013
Q4
$10.4M Sell
123,200
-16,400
-12% -$1.3M ﹤0.01% 1827
2013
Q3
$10.8M Buy
139,600
+64,800
+87% +$4.54M ﹤0.01% 1725
2013
Q2
$4.38M Buy
+74,800
New +$4.5M ﹤0.01% 2411

Other funds holding CELG

Bank of America's CELG Position: Q4 2019 in Review

Bank of America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,074,972 shares — an estimated $405M sold.

Bank of America first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.88B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank of America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank of America sold 4,074,972 Celgene Corp shares in Q4 2019, an estimated $405M.
  • Bank of America first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bank of America's Celgene Corp position peaked at $1.88B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.